266 related articles for article (PubMed ID: 29122358)
21. Development and validation of a radiomics signature on differentially expressed features of
Cao Q; Li Y; Li Z; An D; Li B; Lin Q
Radiother Oncol; 2020 May; 146():9-15. PubMed ID: 32065875
[TBL] [Abstract][Full Text] [Related]
22. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Loo SW; Geropantas K; Beadsmoore C; Montgomery PQ; Martin WM; Roques TW
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):512-7. PubMed ID: 21501953
[TBL] [Abstract][Full Text] [Related]
23. Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.
Adams G; Porceddu SV; Pryor DI; Panizza B; Foote M; Rowan A; Burmeister B
Head Neck; 2014 Aug; 36(8):1200-6. PubMed ID: 23893554
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
Saga T; Inubushi M; Koizumi M; Yoshikawa K; Zhang MR; Obata T; Tanimoto K; Harada R; Uno T; Fujibayashi Y
Ann Nucl Med; 2016 Apr; 30(3):217-24. PubMed ID: 26662072
[TBL] [Abstract][Full Text] [Related]
25. Influence of inter-observer delineation variability on radiomics stability in different tumor sites.
Pavic M; Bogowicz M; Würms X; Glatz S; Finazzi T; Riesterer O; Roesch J; Rudofsky L; Friess M; Veit-Haibach P; Huellner M; Opitz I; Weder W; Frauenfelder T; Guckenberger M; Tanadini-Lang S
Acta Oncol; 2018 Aug; 57(8):1070-1074. PubMed ID: 29513054
[TBL] [Abstract][Full Text] [Related]
26. Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
Van den Wyngaert T; Helsen N; Carp L; Hakim S; Martens MJ; Hutsebaut I; Debruyne PR; Maes ALM; van Dinther J; Van Laer CG; Hoekstra OS; De Bree R; Meersschout SAE; Lenssen O; Vermorken JB; Van den Weyngaert D; Stroobants S;
J Clin Oncol; 2017 Oct; 35(30):3458-3464. PubMed ID: 28854069
[TBL] [Abstract][Full Text] [Related]
27. Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.
Bittner MI; Wiedenmann N; Bucher S; Hentschel M; Mix M; Rücker G; Weber WA; Meyer PT; Werner M; Grosu AL; Kayser G
Acta Oncol; 2016 Nov; 55(11):1299-1304. PubMed ID: 27593107
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET/CT Radiomics Models for The Early Prediction of Locoregional Recurrence in Head and Neck Cancer.
Cong H; Peng W; Tian Z; Vallières M; Chuanpei X; Aijun Z; Benxin Z
Curr Med Imaging; 2021; 17(3):374-383. PubMed ID: 32652919
[TBL] [Abstract][Full Text] [Related]
29. FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer.
Ulrich EJ; Menda Y; Boles Ponto LL; Anderson CM; Smith BJ; Sunderland JJ; Graham MM; Buatti JM; Beichel RR
Tomography; 2019 Mar; 5(1):161-169. PubMed ID: 30854454
[TBL] [Abstract][Full Text] [Related]
30. Detection of subclinical recurrence or second primary cancer using (18) F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma.
Kikuchi M; Shinohara S; Hino M; Itoh K; Tona R; Kishimoto I; Harada H; Fujiwara K; Suehiro A; Naito Y
Head Neck; 2016 Apr; 38 Suppl 1():E511-8. PubMed ID: 25783743
[TBL] [Abstract][Full Text] [Related]
31. The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.
Matoba M; Tuji H; Shimode Y; Kondo T; Oota K; Tonami H
Br J Radiol; 2017 Mar; 90(1071):20150404. PubMed ID: 28055245
[TBL] [Abstract][Full Text] [Related]
32. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
[TBL] [Abstract][Full Text] [Related]
33. Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Chien CR; Liang JA; Kao CH
Laryngoscope; 2014 Dec; 124(12):2732-8. PubMed ID: 25042474
[TBL] [Abstract][Full Text] [Related]
34. Approximation of head and neck cancer volumes in contrast enhanced CT.
Dejaco D; Url C; Schartinger VH; Haug AK; Fischer N; Riedl D; Posch A; Riechelmann H; Widmann G
Cancer Imaging; 2015 Sep; 15():16. PubMed ID: 26419914
[TBL] [Abstract][Full Text] [Related]
35. A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients.
Philip MM; Welch A; McKiddie F; Nath M
Cancer Med; 2023 Aug; 12(15):16181-16194. PubMed ID: 37353996
[TBL] [Abstract][Full Text] [Related]
36. A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer.
Wang K; Zhou Z; Wang R; Chen L; Zhang Q; Sher D; Wang J
Med Phys; 2020 Oct; 47(10):5392-5400. PubMed ID: 32657426
[TBL] [Abstract][Full Text] [Related]
37. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
39. Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Goel R; Moore W; Sumer B; Khan S; Sher D; Subramaniam RM
AJR Am J Roentgenol; 2017 Aug; 209(2):289-303. PubMed ID: 28731808
[TBL] [Abstract][Full Text] [Related]
40. Fusion-based tensor radiomics using reproducible features: Application to survival prediction in head and neck cancer.
Salmanpour MR; Hosseinzadeh M; Rezaeijo SM; Rahmim A
Comput Methods Programs Biomed; 2023 Oct; 240():107714. PubMed ID: 37473589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
